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Hilar cholangiocarcinoma (HCCA) or Klatskin’s disease 
is a devastating tumor originating from the biliary tract 
at the confluence of the right and left hepatic duct. Its 
treatment remains a challenge and the only chance for 
curation is a radical surgical resection [1]. In many cases, 
the disease has already progressed to advanced stages at 
presentation and for these patients surgery is not feasible 
anymore. In contrast, in cases where complete resection 
is obtained, 5- year survival rates of 25–40% have been 
reported [2]. For patients with nonradical resections (R1 
or R2 status) and/or lymph node metastases the survival 
is in most cases comparable to the survival of patients 
without surgical resection [3–10]. In an attempt to achieve 
radical resection, intraoperative frozen section analysis (FS) 
of the surgical margins is used to determine whether an 
additional resection is necessary. This technique is widely 
used in the surgical treatment of various malignancies 
including gynecological, pancreatic, liver, and breast cancer 
[11–14]. However, in the treatment of HCCA the accuracy 
of FS is potentially compromised because of the specific 
pathologic features of the tumor. HCCA is often not a 
bulky tumor, but instead has a branch- like appearance, 
spreading longitudinally along the axis of the bile duct 
wall, partially in the submucosal space with perineural, 
perilymphatic, and perivascular infiltration [15, 16]. This 
growth pattern may result in increased sampling errors.
Further, the clinical implications of a positive result of 
intraoperative frozen section analysis are not always 
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Abstract
Frozen section analysis (FS) during cancer surgery is widely used to assess 
resection margins. However, in hilar cholangiocarcinoma (HCCA), FS may be 
less reliable because of the specific growth characteristics of the tumor. The 
aim of this study was to determine the accuracy and consequences of intraop-
erative FS of the proximal bile duct margins in HCCA. Between 1990 and 2014, 
67 patients underwent combined extrahepatic bile duct resection and partial 
liver resection for HCCA with the use of FS. Sensitivity and specificity of FS 
was 68% and 97%, respectively. Seventeen of 67 patients (25%) displayed a 
positive bile duct margin at FS. The false- negative rate was 16% (eight patients). 
Ten patients (15%) with a positive bile duct margin underwent an additional 
resection in an attempt to achieve negative margins, which succeeded in three 
patients (4%). However, only one of these three patients did not have con-
comitant lymph node metastases, which are associated with a poor prognosis 
by itself. The use of FS of the proximal bile duct is of limited clinical value 
because of the relatively low sensitivity, high risk of false- negative results, and 
the low rate of secondary obtained tumor- free resection margins. Supported by 
the literature, a new approach to the use of FS in HCCA should be adopted, 
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straight- forward. Although a positive bile duct resection 
margin found at FS should guide toward a more extensive 
resection, this is not always possible in the surgical treat-
ment of HCCA. In contrast to a positive margin of the 
distal bile duct, which will result in either a more distal 
dissection of the common bile duct or even in a pan-
creatoduodenectomy, a positive proximal bile duct resection 
margin can put the surgical team in a difficult situation 
because an additional resection of the liver parenchyma 
is often accompanied by increased morbidity or is some-
times anatomically not possible.
Only a few studies have addressed the issue of intra-
operative frozen section analysis of the proximal bile ducts 
HCCA with contradictory results [17–21]. The aim of 
this study was to (1) investigate the accuracy of intraop-
erative frozen section analysis of the proximal bile ducts 
in patients with HCCA and (2) to determine the extent 
to which FS contributes to radical resection of HCCA.
Materials and Methods
Patients
Between January 1990 and June 2014, a total of 74 patients 
underwent extrahepatic bile duct resection combined with 
partial hepatectomy for HCCA at the University Medical 
Center Groningen. In seven patients FS was not performed 
(in one case because Caroli’s disease was suspected and 
in the other cases because a maximum resection was 
performed and it was concluded that FS would not have 
any consequences) resulting in a study group of 67 patients. 
Only patients with adenocarcinoma involving the hepatic 
duct bifurcation (left, right, and/or common hepatic duct) 
were included in this study. Follow- up was continued 
until June 1st, 2015.
Diagnostic work- up
During the entire study period, all patients with (suspected) 
HCCA were discussed in a multidisciplinary team to evalu-
ate eligibility for surgery.
As described previously, the working diagnosis of HCCA 
was based on clinical symptoms (i.e., “silent jaundice”) 
and findings at endoscopic retrograde cholangiopancrea-
ticography (ERCP), magnetic resonance cholangiography 
(MRC), percutaneous transhepatic cholangiography (PTC), 
or combinations thereof [9]. Preoperative pathological 
diagnosis by endoscopic brushings or percutaneous fine- 
needle aspiration was preferred, but in some cases positive 
cytology could not be obtained and the diagnosis was 
based on suspicious radiological characteristics only. In our 
early experience, either an arteriography or a Doppler 
ultrasound of the liver vasculature was performed to 
investigate whether involvement of the portal vein or 
hepatic artery was present. When high- resolution computed 
tomography (CT) angiography became available, four- 
phase imaging of the liver was obtained to assess the 
vascular status. From 2006 magnetic resonance imaging 
(MRI) and magnetic resonance cholangiopancreaticography 
(MRCP) was increasingly used to determine the biliary 
anatomy and progression of the tumor. CT scanning of 
the thorax was performed to exclude metastases. Diagnostic 
laparotomy or laparoscopy to rule out peritoneal metas-
tases prior to definitive surgery was not performed.
Surgical technique
The surgical procedure for resection of HCCA has been 
described previously [9]. Briefly, the procedure started 
with an explorative laparotomy to exclude any peritoneal 
metastases. The liver and hepatoduodenal ligament were 
inspected to determine whether the planned procedure 
was feasible. If during inspection an enlarged lymph node 
was encountered at the aortocaval nodal stations or at 
the celiac trunk (N2 lymph nodes), it was biopsied and 
sent for frozen section analysis. In case frozen section 
analysis showed metastatic tumor cells in the sample, the 
surgical resection was considered futile and the procedure 
was therefore aborted.
The hepatoduodenal ligament was explored, consisting 
of regional lymph node dissection and skeletonization of 
the portal vein and hepatic artery. The distal common 
bile duct was cut at the level of the pancreatic head. The 
distal bile duct resection margin was checked with frozen 
section. In case the distal resection margin was positive, 
a more distal bile duct transection was performed or in 
some cases additional pancreaticoduodenectomy.
The bile duct connecting to the future liver remnant 
was dissected as far as possible into the parenchyma and 
transected. A frozen section of the proximal bile duct 
resection margin was taken to be informed about the 
presence or absence of remnant tumor cells. If a positive 
margin was encountered, it was evaluated whether a more 
extensive resection was possible. In some cases, it was 
concluded that further resection was technically not feasible 
and the procedure was completed with the knowledge of 
performing an R1 resection.
Intraoperative frozen section analysis and 
final pathology
A 2- to 3- mm segment was taken from the cut ends of 
bile ducts for frozen section analysis. An imprint was 
taken from the fresh tissue sample before embedding the 
margin cuff in Tissue- Tek® (Sakura Finetek Europe B.V., 
The Netherlands) and frozen in liquid nitrogen. The 4- μm 
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thick tissue sections were stained with hemotoxylin–eosin, 
while the imprint specimen was Giemsa stained. Both 
specimens were directly analyzed microscopically. 
Following the intraoperative diagnosis, the frozen samples 
were fixed in 10% formalin and embedded in paraffin. 
The 4- μ thick sections were cut from the paraffin blocks 
and stained with hematoxylin–eosin. The paraffin slides 
were microscopically examined and the findings were 
compared with the frozen section results to determine 
concordancy or discordancy between the two samples. 
The surgical margin status of the proximal and distal bile 
ducts was classified as positive when invasive carcinoma 
or carcinoma in situ was identified microscopically.
An R0 (radical surgical resection) resection was defined 
as resection without microscopic tumor cells detected in 
the biliary, vascular, or parenchymal surgical margins. A R1 
resection was defined as microscopic tumor deposits in one 
of the before mentioned surgical margins. A R2 resection 
was defined as a resection with macroscopic tumor deposits 
in one or more of the surgical margins. Nodal status was 
defined positive (N1) if one or more of the hilar lymph 
nodes contained tumor cells. Patients were staged according 
to the sixth edition of the American Joint Committee on 
Cancer (AJCC) TNM staging system for HCCA [22].
Study design and statistical analysis
Patient data and baseline characteristics were retrospectively 
collected in a database and statistical analyses were carried 
out using IBM SPSS Statistics, (IBM, Armonk, New York). 
Continuous variables were expressed as the means ±SD. 
Categorical variables were expressed as numbers and per-
centages. Univariable analyses were conducted for patient 
survival by Kaplan–Meier estimates of survival probabilities 
and the log- rank test for comparisons. P- values of less 
than 0.05 were considered statistically significant.
Accuracy of intraoperative frozen section analysis of 
the bile duct margins was determined by calculating the 
sensitivity, specificity, positive, and negative predictive 
value. Final histopathological evaluation of the paraffin- 
embedded slides was defined as the gold standard.
The consequences of intraoperative frozen section analy-
sis were evaluated in two steps: First, it was assessed 
whether a positive proximal bile duct resection margin 
found at FS resulted in an additional resection or not. 
Second, the final resection status was established at defini-
tive histopathology (radical: R0, or nonradical: R1/R2).
Results
Survival and prognostic factors
Patient, operative and final pathology characteristics of 
the 67 patients who underwent surgical resection for HCCA 
and frozen section analysis of the proximal bile ducts are 
presented in Table 1.
The 90- day mortality was 18% (12 patients), ranging 
from 4 to 80 days. For survival analyses, patients with 90- 
day mortality were excluded. The overall 1- , 3- , and 5- year 
survival rates in the remaining 55 patients was 84%, 46%, 
and 32%, respectively. Prognostic factors for survival were 
identified using univariable analyses (Table 2). Final resec-
tion status approached significance, but only lymph node 
status was shown to be a predictive factor for survival.
Accuracy calculations of frozen 
section analysis
Accuracy calculations of FS of the proximal bile duct 
margins are summarized in Table 3. Sensitivity and speci-
ficity of intraoperative frozen section analysis of the bile 
duct margins were 68% and 97%, respectively. The posi-
tive predictive value and negative predictive value of 
Table 1. Demographics, surgical characteristics, and final pathological 
findings in 67 patients with resected hilar cholangiocarcinoma.
Variable Value





















Arterial and venous 2 (3%)








EHBD, extrahepatic bile duct.
1AJCC TNM staging system (6th edition, 2002).
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intraoperative frozen section analysis of the proximal bile 
duct margins were both 89%.
Consequences of frozen section analysis of 
the proximal bile ducts
The consequences of FS are visualized in Figure 1. Of 
the 67 patients in whom frozen section analysis of the 
proximal bile ducts was performed, 50 patients had a 
negative result. However, in eight of these patients (16%), 
FS was false negative and at final histopathology it was 
found that the proximal bile duct margin was positive 
for remnant tumor cells (R1 resection).
Seventeen patients (25%) had a positive margin at FS. 
In 10 patients (15%), an additional resection of the 
proximal bile duct(s) was performed in an attempt to 
achieve tumor- free bile duct margins. In four patients 
(6%), the additional resections were successful and resulted 
in secondary tumor- free bile duct margins. However, 
final histopathology demonstrated in one of these four 
patients another positive surgical margin (liver 
parenchyma).
The length of the additional resections in the three 
remaining patients was >5 mm. One patient underwent 
an additional liver segment resection with wide margins 
and in the other two an additional proximal bile duct 
resection >5 mm was possible. Two out of three patients 
in which a secondary R0 resection was achieved, showed 
concomitant N1 lymph node metastases. Both patients 
died as a result of tumor recurrence at, respectively, 
7 months and two- and- a- half years after surgery. As a 
consequence, only in one of 67 patients (1.5%) the 
final resection status and prognosis improved by intra-
operative frozen section analysis of the proximal bile 
ducts. This patient is still alive with a follow- up of 
10 years.
Recurrence of disease
For recurrence- of- disease analyses patients with 90- day 
mortality (n = 12) were excluded. There were 21 patients 
with local recurrences and nine patients with distant 
metastases.
Local recurrences were found in 10/30 patients (33%) 
with an R0 resection versus 11/25 patients (44%) with 
an R1 resection (P = 0.43). To investigate the effect of 
final resection status on the probability of recurrence, a 
time- to- recurrence analysis was performed. At 5 years 
follow- up, the estimated probability of recurrence was 
51% in patients with an R0 resection versus 76% in 
patients with an R1 resection (P = 0.15) (Fig. 2). It was 
concluded that final resection status had no impact on 
recurrence rate.
Discussion
This study shows that intraoperative frozen section analysis 
of the proximal bile ducts is of limited value because of 
two reasons.
First, we found a low sensitivity rate of 68%, which 
means that in almost one- third of cases, FS did not detect 
Table 2. Univariable analysis of postoperative survival in patients with 
hilar cholangiocarcinoma.
Variable No. patients % 5- year survival P- value
Age (year)
<60 23 (42%) 28 0.55
≥60 32 (58%) 35
Gender
Male 33 (60%) 37 0.49
Female 22 (40%) 24
Type of hepatectomy
Left 29 (53%) 38 0.39
Right 26 (47%) 24
pT stage1
T1 2 (4%) 100 0.21
T2 29 (53%) 44
T3 24 (43%) 13
Perineural invasion
Negative 9 (19%) 33 0.91
Positive 39 (81%) 35
Lymph node metastases
Negative 31 (56%) 44 0.009
Positive 24 (44%) 17
Final resection status
R0 30 (55%) 39 0.054
R1 25 (45%) 22
Twelve patients with 90- day mortality were excluded from the analysis.
1According to the sixth edition of the AJCC Cancer Staging Manual.
Table 3. Accuracy calculation of frozen section analysis of the proximal 
bile duct margin during surgical resection of hilar cholangio carcinoma1.
 Positive  
resection 




margin at final 
pathology
Positive result intraoperative 
frozen section analysis
17 2 19






Positive likelihood ratio 22
Positive predictive value 89%
Negative predictive value 89%
1In some patients more than one proximal bile duct was examined by 
frozen section analysis.
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tumor cells at the resection margin. In addition, the false- 
negative rate of 16% was relatively high, corresponding 
to eight patients, in whom an additional resection was 
erroneously withheld, resulting in suboptimal treatment. 
The best explanation for the impaired sensitivity of intra-
operative frozen section analysis in HCCA is the specific 
growth pattern of the tumor, which is characterized by 
a longitudinal, infiltrative extension along the mucosa and 
submucosal spaces leading to sampling errors [15, 16]. 
A few studies are available describing the use of frozen 
section analysis in the treatment of HCCA (Table 4). Only 
Okazaki et al. [17] reported a sensitivity rate of 75%, 
which is comparable to the sensitivity rate of 68% found 
in this study. However, most studies did specify their 
rate of false- negative results, ranging from 2 to 28. [17–20] 
The false- negative rate of 16% in our series is therefore 
in accordance with the literature.
Second, the extent to which FS contributed to radical 
resections was low, because in only three patients a sec-
ondary R0 resection could be achieved. In all other cases, 
additional resection was not possible or failed in its goal 
to obtain a negative bile duct margin. Table 4 shows 
Figure 1. Flow diagram elucidating proximal bile duct margin status at intraoperative and final pathology, additional proximal bile duct resections, 
other margins’ positivity, final pathology, and defintive lymph node status.
Figure 2. Cumulative probability of reccurence after resection for hilar 
cholangiocarcinoma according to final resection status (R0 vs. R1). 
Patients with in- hospital mortality were excluded from the analysis. 
P = 0.15 (log- rank test).
No. at risk
R0 resection 0 6 10 13 14 14
R1 resection 0 5 11 15 15 16
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that low rates of secondary obtained R0 resections (4–9%) 
are reported by most authors. [18–20] In many cases, 
additional resection guided by a positive result of frozen 
section analysis is not possible from anatomic and techni-
cal points of view. An exception to the rule is the article 
from Ribero et al. [21] which showed a secondary R0 
resection rate of 19%. A possible explanation for this 
difference is that these authors performed relatively minor 
resections as was suggested by one of the discussants at 
the end of the article. However, the distribution of 
(extended) left and (extended) right hepatectomy was very 
comparable to our series. It should be noted that the 
high rate of secondary obtained R0 resections in this 
study was accompanied by a high rate of postoperative 
complications, especially biliary fistula, suggesting that 
additional resections are indeed technically demanding 
[21].
An important question is whether or not a secondary 
R0 resection will improve prognosis. Unfortunately, our 
numbers were not large enough to allow a survival analysis 
comparing patients with a secondary obtained R0 resec-
tion to those with an R1 or primary R0 resection. Table 4 
shows that four authors addressed this issue. Endo et al. 
[18] and Shingu et al. [19] were able to perform a formal 
survival analysis and found that secondary obtained R0 
resections did not improve prognosis. Survival in the 
secondary R0 group was comparable to the group with 
R1 resections. Lee et al. [20] did not perform a survival 
analysis, but noticed disease recurrence and subsequent 
tumor- induced death in five of seven patients with a 
secondary obtained R0 resections. These authors also con-
cluded that there was no survival benefit of secondary 
achieved radical resections. Ribero et al. [21] published 
the only study in which an improvement in prognosis 
was found in the secondary R0 group. Thirteen patients 
in this group had a 5- year survival rate of 50% which 
was comparable to the primary R0 group (5- year survival 
rate of 31%) and significantly better than the R1 group 
(5- year survival rate of 0%).
In the present study, lymph node status was deliberately 
included in the overview of the final pathology. The pres-
ence of regional lymph node metastases has repeatedly 
been shown to have a negative impact on survival [4, 
23, 24], which was also confirmed in our univariable 
analysis (Table 2). When brought into consideration, 
regional lymph node metastases were found in two of 
three patients with a secondary obtained R0 resection, 
which is detrimental to the expected prognosis. In ret-
rospect, it can be concluded that of 67 patients in which 
frozen section analysis was performed, only one patient 
ultimately benefitted from the procedure because in this 
patient resection margins as well as lymph node status 
were negative.
Considering the low sensitivity rate, high false- negative 
rate, and low rate of secondary achieved R0 resections 
in our series, together with the lack of improved survival 
after secondary R0 resection reported by most authors in 
the literature, it could be concluded that frozen section 
analysis has no value in the treatment of HCCA. Some 
authors have advocated performing extended resections 
as the surgical procedure of choice since it results in the 
highest rates of R0 resections and 5- year survival. [25] 
When adopting this strategy, frozen section analysis of 
the proximal bile duct can indeed be abandoned because 
further resection will be impossible. However, an interest-
ing observation was made by Endo et al. [18] that patients 
with a wide resection margin of the proximal bile duct 
showed a significant better 5- year survival than patients 
with a narrow resection margin, 43% versus 18%, respec-
tively. It therefore seems reasonable to not completely 
abandon the use of frozen section analysis of the proximal 
bile ducts, but to reserve this technique only for those 
cases in which an additional resection with substantial 
length is possible. The length of the additional resection 
could be estimated on >5 mm since a tumor- free proximal 
bile duct margin of 5 mm was found to be sufficient in 
avoiding local recurrences [26].
Our study has a number of disadvantages related to 
its retrospective design and limited number of patients, 
which prevented us from performing a survival analysis 
of the secondary R0 group. However, as can be concluded 
from Table 4, limited numbers are common in most 
studies of HCCA since hilar cholangiocarcinoma is a rare 
disease.














Okazaki et al., 
2002 [17]
23 75% 0 (0%) –
Endo et al., 
2008 [18]
101 NR 9 (9%) no
Shingu et al., 
2009 [19]
138 NR 8 (6%) no
Ribero et al., 
2011 [21]
67 NR 13 (19%) yes
Lee et al., 
2012 [20]
162 NR 7 (4%) no
Present study 67 68% 3 (4%) –
NR: not reported.
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Conclusions
In conclusion, this study shows that the use of intraopera-
tive frozen section analysis of the proximal bile ducts has 
a low sensitivity, high rate of false- negative results, and a 
limited contribution in obtaining secondary R0 resections. 
This finding, together with the fact that secondary R0 resec-
tions do not improve survival in most reports in the lit-
erature, justifies a new approach to the use of FS, reserving 
the technique only for those cases in which a substantial 
additional resection is possible.
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